CFRHF (Compagnie Financiere Richemont) Research & Development: $0 Mil (TTM As of Mar. 2026)


CFRHF Compagnie Financiere Richemont SA CFRHF
92 GF Score
Price $229.86
GF Value $186.03
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Compagnie Financiere Richemont Research & Development?

Compagnie Financiere Richemont CFRHF +3.74% 92 Research & Development is $0 Mil as of Mar. 2026. GuruFocus rates CFRHF with a GF Score™ of 92/100 and a GF Value™ of $186.03 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Compagnie Financiere Richemont's Research & Development for the six months ended in Mar. 2026 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0 Mil.

Compagnie Financiere Richemont  (OTCPK:CFRHF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Compagnie Financiere Richemont Research & Development Related Terms

Compagnie Financiere Richemont Research & Development Historical Data

* Premium members only.

The historical data trend for Compagnie Financiere Richemont's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Compagnie Financiere Richemont Research & Development Chart

Compagnie Financiere Richemont Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Compagnie Financiere Richemont Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CFRHF
92GF Score
Compagnie Financiere Richemont SA CFRHF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Compagnie Financiere Richemont Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
Compagnie Financiere Richemont (CFRHF) has a Research & Development of $0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Compagnie Financiere Richemont and its competitors.
Is Compagnie Financiere Richemont's Research & Development too high?
Compagnie Financiere Richemont's current Research & Development is $0 Mil. Overall, Compagnie Financiere Richemont has a GF Score™ of 92/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Compagnie Financiere Richemont's Research & Development compare to TPR and SIG?
Compagnie Financiere Richemont's Research & Development of $0 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Retail - Cyclical company?
A good Research & Development depends on the Retail - Cyclical industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Compagnie Financiere Richemont and its competitors. Compagnie Financiere Richemont's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Compagnie Financiere Richemont stock overvalued right now?
Based on GuruFocus' analysis, Compagnie Financiere Richemont (CFRHF) is currently considered Modestly Overvalued. The stock's GF Value™ is $186.03, compared to a current price of $229.86 — trading 23.6% above its estimated fair value. The current Research & Development is $0 Mil. Compagnie Financiere Richemont's overall GF Score™ is 92/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Compagnie Financiere Richemont (CFRHF), the current Research & Development is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Compagnie Financiere Richemont (CFRHF) Overvalued in 2026?

Based on GuruFocus' analysis, Compagnie Financiere Richemont stock appears to be overvalued. The current stock price of $229.86 is trading 23.6% above its estimated GF Value™ of $186.03. GuruFocus considers Compagnie Financiere Richemont to be Modestly Overvalued.

Key valuation signals for CFRHF:

  • Research & Development: $0 Mil
  • GF Value™: $186.03 vs. price of $229.86 (23.6% above fair value)
  • GF Score™: 92/100 with 5 warning signs

No single metric tells the full story. See the CFRHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Compagnie Financiere Richemont Business Description

Address 50 Chemin de la Chenaie, CP 30, Bellevue, Geneva, CHE, 1293
Richemont is a luxury goods conglomerate with 20 brands. Jewelry and watch brands make up 87% of sales, but the group is also active in accessories, writing instruments, clothing, and online luxury retail. Richemont's Jewellery Maisons, including Cartier and Van Cleef & Arpels, account for over 70% of revenue and the vast majority of profits. Its other brands include Vacheron Constantin, Piaget, Jaeger-LeCoultre, IWC Schaffhausen, Lange & Soehne, Officine Panerai, Chloe, and Montblanc.
92GF Score

Get the complete analysis for CFRHF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$229.86
Price
$186.03
GF Value